A Retrospective Assessment of Changes in Stroke Risk-Related Biomarkers in Individuals with Prediabetes from Durban, South Africa: Preliminary Findings
Open Access
- 24 October 2025
- journal article
- research article
- Published by MDPI AG in Current Issues in Molecular Biology
- Vol. 47 (11) , 884
Abstract
Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder that significantly increases the risk of stroke, with prediabetes serving as an intermediate stage marked by similar pathophysiological mechanisms such as inflammation and vascular dysfunction. This study investigated the relationship between prediabetes and stroke-related biomarkers in individuals aged 25–45 years in Durban, South Africa. After obtaining ethical approval, a retrospective analysis was performed on blood samples from 100 participants recruited from King Edward Hospital and Inkosi Albert Luthuli Central Hospital. Participants were classified as non-prediabetic (n = 30), prediabetic (n = 35), or type 2 diabetic (n = 35) according to ADA criteria. Plasma concentrations of C-reactive protein (CRP), interleukin-6 (IL-6), fibrinogen, D-dimer, calcium binding protein (S100B), glial fibrillary acidic protein (GFAP), and neuron-specific enolase (NSE) were measured using enzyme-linked immunosorbent assay (ELISA). It is important to note that none of the participants had confirmed stroke events; these biomarkers were assessed as surrogate indicators of stroke risk. Statistical analyses included one-way ANOVA with Tukey–Kramer tests and Pearson’s correlations. Biomarker concentrations were significantly elevated in prediabetic individuals compared to non-prediabetic controls, with levels further increasing in T2DM. Strong positive correlations were observed between S100B and both HbA1c (r = 0.75, p < 0.0001) and fasting glucose (r = 0.75, p < 0.0001). These findings suggest that inflammatory, coagulation, and neurovascular biomarkers, particularly S100B, may indicate early stroke risk in prediabetes. Further investigation into these biomarkers could improve early detection strategies and stroke prevention efforts in at-risk populations.Keywords
Funding Information
- College of Health Science
This publication has 76 references indexed in Scilit:
- Oxidative stress as a bridge between age and stroke: A narrative reviewJournal of Intensive Medicine, 2023
- Serum Levels of Glial Fibrillary Acidic Protein Association with Cognitive Impairment and Type 2 DiabetesArchives of Medical Research, 2022
- Pre-Diabetes Increases Stroke Risk in Patients With Nonvalvular Atrial FibrillationJACC, 2021
- Correction of serum NSE reference intervals includes the unidentified hemolysis sample: 1‐year data analysis from healthcare individualsJournal of Clinical Laboratory Analysis, 2019
- Diabetes and Stroke: Epidemiology, Pathophysiology, Pharmaceuticals and OutcomesThe American Journal of the Medical Sciences, 2016
- Prognostic value of neuron specific enolase and IL-10 in ischemic stroke and its correlation with degree of neurological deficitClinica Chimica Acta, 2013
- Short-term prognostic value of serum neuron specific enolase and S100B in acute stroke patientsClinical Biochemistry, 2012
- The predictive value of TNF-α and IL-6 and the incidence of macrovascular complications in patients with type 2 diabetesActa Diabetologica, 2010
- C-reactive protein in the very early phase of acute ischemic stroke: association with poor outcome and deathJournal of Neurology, 2009
- Interleukin-6 as a key player in systemic inflammation and joint destructionAutoimmunity Reviews, 2009